Status:
WITHDRAWN
Docosahexaenoic Acid (DHA) Administration and Length of Gestation: a Feasibility Study
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
DSM Nutritional Products, Inc.
Conditions:
Premature Birth
Eligibility:
FEMALE
Phase:
NA
Brief Summary
This is a feasibility study to determine if it will be possible to conduct a larger study of the effect of docosahexaenoic acid (DHA), an omega fatty acid, on increased length of gestation among women...
Detailed Description
We propose to conduct an 18-month feasibility study to determine (a) how many women we could approach during a 4-month period, (b) how many of these women would be eligible for a future RCT, (c) how m...
Eligibility Criteria
Inclusion
- Previous preterm delivery (delivery prior to 37 completed weeks of gestation)
Exclusion
- None
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00691418
Start Date
July 1 2008
End Date
August 1 2009
Last Update
March 6 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.